PL
PL
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
1
$566K
Total Volume
$566K
1 transactions
Net Activity
$566K
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
PL has an insider buy conviction of 0%, compared to the Unknown sector buy average of 20%.
Robinson Kristen
Dir
$566K total
Over the last 90 days, corporate insiders at PL (PL) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $566K.
The net insider activity for PL shows a net selling bias of $566K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Robinson Kristen (Dir), who traded 40.0K shares valued at $566K on Oct 15, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering PL and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
Deciphering Form 5 Filings: Uncovering Annual Insider Gift Trades
A comprehensive guide to SEC Form 5 filings, explaining how annual reports of gift shares, stock options, and non-open-market transactions signal insider sentiment.
The Role of Venture Partners on Public Boards: Tracking a16z and Sequoia Directors
When a16z or Sequoia places a partner on a public company board, they become Section 16 insiders and must file Form 4. This report tracks VC-director trading patterns at major portfolio companies and what their transactions signal to outside investors.
Spotting Insider Sells: When to Worry and When to Ignore
Most insider sales are irrelevant, estate planning, tax obligations, diversification. But certain Form 4 selling patterns are genuine red flags. This guide teaches you exactly when to worry: cluster sells, CEO departures, and pre-restatement patterns.
Insider Trading and Earnings Announcements: Spotting the Catalyst
How does insider trading activity in the 30 days before earnings compare to post-announcement prices? This study quantifies the predictive power of pre-earnings Form 4 purchases after accounting for blackout period compliance.
Venture Spinoffs vs. Direct Listings: A Comparative Analysis of Insider Holding Trends
Venture-backed spinoffs and direct listings both skip traditional IPO underwriting, but their insider holding dynamics differ sharply. This study compares Form 4 patterns at spinoff-versus-direct-listing companies to identify which structure produces stronger alignment signals.
FAQs About PL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for PL.